One of the notable transforming changes that have been observed recently is the rising adoption of biosimilars like Ustekinumab (Stelara), which is modernizing the specialty of pharmacy billing by incorporating new operational healthcare methods. These biological products offer clinical outcomes comparable to their reference therapies, while being more cost effective.
Read More